10 free, board-style Cardiovascular questions for the PANRE, each with the correct answer and a complete explanation. No email, no account required.
Cardiovascular is 12% of the PANRE content blueprint. These questions come from the clinician-reviewed FirstPassPA bank. Attempt each one before you reveal the answer.
Question 1CardiovascularMedium
A 70-year-old woman with known rheumatic mitral stenosis presents with acute dyspnea. An echocardiogram 3 months ago showed a mitral valve area of 1.0 cm2 and a left ventricular ejection fraction of 60%. She is found to be in new atrial fibrillation at a ventricular rate of 145 beats per minute, with bibasilar crackles, an oxygen saturation of 88% on room air, and frothy sputum consistent with acute pulmonary edema. Her blood pressure is 118/76 mm Hg. She is alert with warm extremities, and her oxygen saturation improves to 93% on supplemental oxygen. Which of the following is the most appropriate initial intervention to relieve her pulmonary edema?
AIntravenous metoprolol
BSurgical mitral valve replacement
CPercutaneous mitral balloon commissurotomy
DIntravenous adenosine
EIntravenous amiodarone
Reveal answer & full explanation
Correct answer: A — Intravenous metoprolol
AIntravenous metoprolol✓
BSurgical mitral valve replacement
CPercutaneous mitral balloon commissurotomy
DIntravenous adenosine
EIntravenous amiodarone
Why Intravenous metoprolol is correct
In mitral stenosis, left atrial emptying depends on adequate diastolic filling time; tachycardia shortens diastole, raises left atrial pressure, and rapidly drives pulmonary edema.
New atrial fibrillation at 145/min is what tipped her severe stenosis (mitral valve area 1.0 cm2) into pulmonary edema. IV metoprolol slows AV-nodal conduction, lengthens diastolic filling time, and lowers left atrial and pulmonary venous pressure. It treats the cause of the edema, which is why it is the best answer to what is asked.
IV beta blockers are recommended for acute rate control of AF with a rapid ventricular response in hemodynamically stable patients (2023 ACC/AHA/ACCP/HRS AF guideline, COR 1). Heart rate control is also reasonable in rheumatic mitral stenosis with AF and a rapid ventricular response (2020 ACC/AHA valvular heart disease guideline, COR 2a).
She can tolerate IV beta-blockade because her blood pressure is preserved (118/76 mm Hg), she is perfusing well (alert, warm extremities), her oxygenation responds to supplemental oxygen, and her LVEF is 60%. A normal blood pressure alone would not establish this. LV systolic function is usually preserved in mitral stenosis because the obstruction lies upstream of the LV.
An IV loop diuretic is appropriate concurrent therapy for her congestion. It lowers left atrial pressure by reducing volume, but it does not slow the ventricular rate or lengthen diastole, so it does not correct the rate-driven cause.
Why the others are wrong
Intravenous adenosine — Adenosine blocks the AV node for only seconds because its half-life is very short. It does not convert atrial fibrillation to sinus rhythm; it only transiently slows the ventricular response. The rate returns to about 145/min almost at once, so diastolic filling time is never restored. Adenosine terminates reentrant SVTs whose circuit runs through the AV node; AF arises in the atria and does not need the AV node to continue (the trap is applying the SVT algorithm to atrial fibrillation).
Percutaneous mitral balloon commissurotomy — This is the definitive treatment for symptomatic severe mitral stenosis with suitable valve anatomy, but it is an elective or semi-elective procedure that does not address this acute decompensation in real time.
Surgical mitral valve replacement — Reserved for severe disease unsuitable for balloon valvuloplasty or with significant mitral regurgitation; not an emergency intervention for acute rate-driven pulmonary edema.
Intravenous amiodarone — it does slow AV-nodal conduction and is tempting in a patient in pulmonary edema, but IV amiodarone is not a preferred rate-control agent; it is reserved for when beta blockers and non-dihydropyridine calcium channel blockers are ineffective or contraindicated, and it can chemically cardiovert a patient with rheumatic mitral stenosis who is not yet anticoagulated (the trap is reaching for the antiarrhythmic first).
Additional high-yield points
Initial stabilization happens in parallel: supplemental oxygen (noninvasive ventilation if hypoxemia persists), IV rate control, an IV loop diuretic for congestion, and anticoagulation. Valvular intervention is considered only once she is stable.
Immediate synchronized cardioversion is indicated for hemodynamic instability attributable to AF (2023 AF guideline, COR 1). Instability means hypotension or shock, ongoing ischemia, altered mentation, or pulmonary edema that worsens or does not respond despite rate control. The valvular guideline adds that cardioversion may be needed if the rate cannot be controlled with medications.
IV diltiazem is an equally recommended alternative when LVEF is >40%, as it is here. IV non-dihydropyridine calcium channel blockers are Class 3: Harm in known moderate or severe LV systolic dysfunction.
IV amiodarone is not a preferred rate-control agent. It is reserved for patients in whom beta blockers and non-dihydropyridine calcium channel blockers are ineffective or contraindicated (2023 AF guideline: COR 2b for critically ill or decompensated heart failure patients in the acute rate-control section, COR 2a in the section on AF with heart failure).
Anticoagulate: rheumatic mitral stenosis with AF calls for a vitamin K antagonist (2020 valvular guideline, COR 1), typically heparin acutely, then warfarin. Warfarin is recommended over DOACs in this setting (2023 AF guideline).
A mitral valve area of 1.5 cm2 or less defines severe stenosis. Once she is stable, she should be evaluated for PMBC. TEE comes first to exclude left atrial thrombus and more than mild mitral regurgitation, and surgery is reserved for patients who are not PMBC candidates.
Question 2CardiovascularMedium
A 40-year-old woman has recurrent paroxysmal supraventricular tachycardia (SVT) confirmed on Holter monitoring and declines catheter ablation. Which of the following oral medications is preferred for long-term prophylaxis?
AFlecainide
BMetoprolol
CDigoxin
DNifedipine
EAmiodarone
Reveal answer & full explanation
Correct answer: B — Metoprolol
AFlecainide
BMetoprolol✓
CDigoxin
DNifedipine
EAmiodarone
Why Metoprolol is correct
For long-term supraventricular tachycardia (SVT) prophylaxis in a structurally normal heart, oral beta-blockers (metoprolol) or non-dihydropyridine calcium channel blockers (diltiazem, verapamil) are first-line because they are safe and well-tolerated
Why the others are wrong
Flecainide — flecainide and propafenone can be used in SVT prophylaxis but require a structurally normal heart to be considered; they are not the preferred first-line agents here
Amiodarone — amiodarone is not preferred for SVT prophylaxis due to its significant toxicity profile
Digoxin — digoxin is not a preferred long-term prophylactic agent for SVT
Nifedipine — a calcium channel blocker, but a dihydropyridine that acts on vascular smooth muscle with little effect on AV-nodal conduction and can cause reflex tachycardia; the calcium channel blockers used for SVT prophylaxis are the non-dihydropyridines (diltiazem, verapamil)
Additional high-yield points
Catheter ablation is curative in >95% of cases and is the preferred definitive treatment option
Question 3CardiovascularMedium
A 62-year-old man with metastatic lung cancer presents with progressive dyspnea and lightheadedness for two days. Vital signs show HR 128, BP 82/64, RR 26, and SpO2 92% on room air. Exam reveals jugular venous distention to the angle of the jaw, muffled heart sounds, a pulsus paradoxus of 18 mmHg, and cool extremities. Lungs are clear bilaterally. ECG shows low voltage with electrical alternans and bedside ultrasound demonstrates a large pericardial effusion with right atrial and right ventricular diastolic collapse. Which of the following is the most likely diagnosis?
AConstrictive pericarditis
BMassive pulmonary embolism
CCardiac tamponade
DAcute decompensated heart failure
ERight ventricular infarction
Reveal answer & full explanation
Correct answer: C — Cardiac tamponade
AConstrictive pericarditis
BMassive pulmonary embolism
CCardiac tamponade✓
DAcute decompensated heart failure
ERight ventricular infarction
Why Cardiac tamponade is correct
This is obstructive shock from cardiac tamponade due to malignant pericardial effusion.
The Beck triad (hypotension, JVD, muffled heart sounds) plus pulsus paradoxus >10 mmHg, low-voltage ECG with electrical alternans, and echocardiographic right-heart diastolic collapse are pathognomonic.
Recognition is critical because emergent pericardiocentesis is life-saving.
Why the others are wrong
Massive pulmonary embolism — Causes obstructive shock with JVD and a strain pattern on ECG (S1Q3T3, RBBB) but lacks an effusion with diastolic chamber collapse on echo.
Right ventricular infarction — Also produces hypotension with marked JVD and clear lungs, but the ECG shows inferior ST elevation with ST elevation in V4R rather than low voltage with electrical alternans, and echo shows a dilated hypokinetic right ventricle rather than a large effusion compressing the chambers.
Acute decompensated heart failure — Produces pulmonary congestion with rales, an S3, and elevated JVP but not muffled heart sounds, pulsus paradoxus, or chamber collapse from external compression.
Constrictive pericarditis — Also raises venous pressure with clear lungs and can follow malignancy or chest radiation, but it usually develops gradually over months, may produce a Kussmaul sign or a pericardial knock, and on imaging typically shows a thickened pericardium rather than a large effusion; electrical alternans and right-heart diastolic collapse are features of tamponade, not constriction.
Question 4CardiovascularMedium
A 54-year-old woman with a history of childhood rheumatic fever presents with progressive abdominal swelling, lower-extremity edema, and fatigue. Examination shows jugular venous distention with prominent a-waves, hepatomegaly, ascites, and a low-pitched diastolic rumble at the left lower sternal border that increases with inspiration. Echocardiography shows a thickened, calcified, immobile tricuspid valve with a mean diastolic gradient of 8 mmHg, a valve area of 0.8 cm², and coexisting moderate-to-severe tricuspid regurgitation. She remains in NYHA class III despite maximal diuretic therapy. Which of the following is the most appropriate management?
APercutaneous balloon tricuspid valvuloplasty
BTranscatheter tricuspid edge-to-edge repair
CTricuspid valve replacement
DTricuspid annuloplasty
ELong-term oral anticoagulation alone
Reveal answer & full explanation
Correct answer: C — Tricuspid valve replacement
APercutaneous balloon tricuspid valvuloplasty
BTranscatheter tricuspid edge-to-edge repair
CTricuspid valve replacement✓
DTricuspid annuloplasty
ELong-term oral anticoagulation alone
Why Tricuspid valve replacement is correct
The right-sided diastolic rumble that augments with inspiration (Carvallo sign), giant a-waves, and systemic venous congestion (JVD, hepatomegaly, ascites) localize the lesion to the tricuspid valve, and echocardiography confirms severe rheumatic tricuspid stenosis (mean gradient >5 mmHg, valve area <1.0 cm²).
She has NYHA class III symptoms refractory to maximal diuresis, so mechanical relief of the fixed obstruction is required.
Because the valve is calcified and immobile with coexisting moderate-to-severe regurgitation, valve replacement (typically a bioprosthesis on the low-pressure right side) is the guideline-preferred surgical treatment for symptomatic severe tricuspid stenosis, per current ACC/AHA valvular disease guidance.
Why the others are wrong
Tricuspid annuloplasty — Annuloplasty tightens a dilated annulus to correct functional regurgitation and does nothing for a fixed, calcified, immobile orifice, so the 8 mmHg diastolic gradient and venous congestion would persist (right-operation-wrong-lesion).
Percutaneous balloon tricuspid valvuloplasty — Balloon valvuloplasty is considered only for pliable, non-calcified valves without significant regurgitation; on a calcified, immobile valve it poorly relieves the gradient and would worsen the existing regurgitation (right-procedure-wrong-substrate).
Long-term oral anticoagulation alone — Anticoagulation does not relieve the mechanical obstruction driving venous congestion and ascites (premature closure on medical therapy).
Transcatheter tricuspid edge-to-edge repair — transcatheter edge-to-edge repair is now offered to selected patients with symptomatic severe tricuspid regurgitation, and her coexisting regurgitation makes it tempting; but clipping the leaflets together narrows the orifice further, so on a stenotic, calcified, immobile valve it would raise the diastolic gradient rather than relieve the obstruction (treating the regurgitation while ignoring the stenosis).
Question 5CardiovascularMedium
A 67-year-old man with hypertension and hyperlipidemia who smoked one pack per day for 40 years and quit 3 years ago presents for routine care. He is asymptomatic with an unremarkable abdominal exam and has never been screened for abdominal aortic aneurysm. According to USPSTF guidelines, which of the following best supports one-time abdominal ultrasound screening for AAA in this patient?
AAge 65-75 and male sex alone
BAny age with 20 or more pack-years
CAge 65-75 with hypertension
DQuit smoking within the past 5 years
EAge 65-75 with prior tobacco use
Reveal answer & full explanation
Correct answer: E — Age 65-75 with prior tobacco use
AAge 65-75 and male sex alone
BAny age with 20 or more pack-years
CAge 65-75 with hypertension
DQuit smoking within the past 5 years
EAge 65-75 with prior tobacco use✓
Why Age 65-75 with prior tobacco use is correct
The USPSTF gives a Grade B recommendation for one-time AAA screening with abdominal ultrasound in men aged 65-75 who have ever smoked.
Why the others are wrong
Quit smoking within the past 5 years — eligibility turns on ever having smoked, not on how recently the patient quit; he would qualify whether he stopped 3 years ago or 30
Age 65-75 with hypertension — hypertension promotes aneurysm growth but is not a USPSTF screening criterion; the smoking history is what qualifies him
Any age with 20 or more pack-years — the 20 pack-year threshold belongs to USPSTF low-dose CT lung cancer screening; AAA screening uses no pack-year cutoff and applies only to ages 65-75
Age 65-75 and male sex alone — the age window is the part most students remember, but for men aged 65-75 who have never smoked the USPSTF advises only selective screening (Grade C); male sex and age alone do not carry the Grade B recommendation that his smoking history does
Additional high-yield points
Men aged 65-75 who never smoked are screened selectively (Grade C).
Women who never smoked are not recommended for screening (Grade D).
Women who smoked or have a family history have insufficient evidence (Grade I).
Ever-smoking paired with the 65-75 age window is the qualifying combination; hypertension, timing of cessation, and pack-year thresholds are not USPSTF AAA criteria.
Question 6CardiovascularMedium
A 58-year-old man with hypertension and diabetes presents to the emergency department with 45 minutes of crushing chest pain radiating to the left arm. He is diaphoretic and confused. Blood pressure is 88/60 mm Hg and pulse is 112/min. ECG shows ST-segment elevation in leads V1 through V4. Which of the following is the most appropriate immediate intervention?
APrimary percutaneous coronary intervention
BIntravenous beta-blockade with metoprolol
CFibrinolysis with tissue plasminogen activator
DIntravenous analgesia with morphine sulfate
EIntra-aortic balloon pump counterpulsation
Reveal answer & full explanation
Correct answer: A — Primary percutaneous coronary intervention
APrimary percutaneous coronary intervention✓
BIntravenous beta-blockade with metoprolol
CFibrinolysis with tissue plasminogen activator
DIntravenous analgesia with morphine sulfate
EIntra-aortic balloon pump counterpulsation
Why primary percutaneous coronary intervention is correct
Anterior ST-elevation MI (ST elevation in V1–V4) complicated by cardiogenic shock (hypotension 88/60 mm Hg, tachycardia, confusion, diaphoresis) requires immediate reperfusion
Primary PCI is the preferred reperfusion strategy in STEMI with cardiogenic shock and is favored over fibrinolysis whenever it can be performed promptly, per current ACC/AHA STEMI guidance
Early revascularization improves survival in cardiogenic shock; the door-to-balloon target is under 90 minutes
Why the others are wrong
Fibrinolysis with tissue plasminogen activator — reserved for when timely PCI is unavailable and markedly inferior to PCI in cardiogenic shock (right-diagnosis-wrong-step: correct goal of reperfusion, wrong modality here)
Intravenous beta-blockade with metoprolol — beta-blockers are contraindicated in cardiogenic shock and acute decompensated heart failure and can precipitate arrest in a hypotensive patient (anchoring on routine early-STEMI order sets without registering the shock contraindication)
Intravenous analgesia with morphine sulfate — relieves pain but does not reperfuse the occluded artery and can lower blood pressure further (buzzword-matching the "MONA" mnemonic instead of prioritizing reperfusion)
Intra-aortic balloon pump counterpulsation — tempting because it provides mechanical hemodynamic support for a hypotensive patient, but it does not reopen the occluded artery, and in IABP-SHOCK II routine IABP added to early revascularization did not reduce mortality, so it is not recommended routinely in infarct-related cardiogenic shock (right-diagnosis-wrong-step: supporting the pressure instead of reperfusing the artery)
Question 7CardiovascularMedium
A 44-year-old woman has 3 days of sharp left-sided chest pain that worsens when she lies flat and improves when she leans forward, two weeks after a viral upper respiratory illness. ECG shows diffuse ST-segment elevation with PR-segment depression. Troponin I is mildly elevated at 0.06 ng/mL (upper reference limit 0.04 ng/mL). Which of the following is the most likely diagnosis?
ACostochondritis
BST-elevation myocardial infarction
CMyopericarditis
DTakotsubo cardiomyopathy
EPulmonary embolism
Reveal answer & full explanation
Correct answer: C — Myopericarditis
ACostochondritis
BST-elevation myocardial infarction
CMyopericarditis✓
DTakotsubo cardiomyopathy
EPulmonary embolism
Why myopericarditis is correct
Positional, pleuritic chest pain (worse supine, better leaning forward) after a recent viral illness, with diffuse ST-segment elevation and PR-segment depression, is the classic picture of acute pericarditis
The mildly elevated troponin indicates accompanying myocardial inflammation, making this myopericarditis rather than isolated pericarditis
Management is NSAIDs plus colchicine, with exercise restriction for at least 1 month and until clinical remission (ESC 2025), longer while myocardial involvement persists
Why the others are wrong
Costochondritis — reproducible chest-wall pain that does not cause diffuse ST elevation, PR depression, or troponin elevation (premature closure on a benign musculoskeletal cause)
ST-elevation myocardial infarction — coronary occlusion produces convex ST elevation confined to a vascular territory with reciprocal depression and a markedly higher troponin, not diffuse concave elevation with PR depression (anchoring on the ST elevation itself)
Pulmonary embolism — shares pleuritic pain, but the ECG would show sinus tachycardia or right-heart strain rather than diffuse ST elevation with PR depression (buzzword-matching pleuritic pain)
Takotsubo cardiomyopathy — stress cardiomyopathy also produces ST elevation with a modest troponin rise, mostly in women, but it typically follows an emotional or physical stressor, causes nonpositional ischemic-type pain, and PR depression is not part of its ECG picture; positional pain after a viral illness with diffuse ST elevation and PR depression is pericardial (pattern-matching ST elevation plus troponin in a woman)
Question 8CardiovascularMedium
A 66-year-old man with peripheral artery disease and an ankle-brachial index of 0.55 one year ago returns with 2 months of progressively severe right foot pain that now occurs at rest, worsens with leg elevation, and improves when he dangles the foot over the bedside. He has a non-healing ulcer on the right great toe. He has no diabetes. The right foot is cool with absent pedal pulses. Repeat ankle-brachial index is 0.32. Which of the following is the most likely diagnosis?
AChronic limb-threatening ischemia
BIntermittent claudication
CNeuropathic ulceration
DVenous stasis ulceration
EAcute thrombotic limb ischemia
Reveal answer & full explanation
Correct answer: A — Chronic limb-threatening ischemia
AChronic limb-threatening ischemia✓
BIntermittent claudication
CNeuropathic ulceration
DVenous stasis ulceration
EAcute thrombotic limb ischemia
Why Chronic limb-threatening ischemia is correct
Chronic limb-threatening ischemia (CLTI), the term that replaced critical limb ischemia in the 2024 ACC/AHA multisociety peripheral artery disease (PAD) guideline, is a clinical diagnosis: more than 2 weeks of ischemic rest pain, a nonhealing wound or ulcer, or gangrene attributable to objectively proven arterial occlusive disease.
He has two qualifying features: foot pain that has progressed over 2 months to pain at rest, and a nonhealing great-toe ulcer. His low ankle-brachial index (ABI) of 0.32, down from 0.55, supports objectively proven arterial occlusive disease, but no ABI value defines CLTI.
Ischemic rest pain typically affects the forefoot, worsens with limb elevation, and is relieved by dependency, which is why he dangles the foot over the bedside.
Timely treatment is essential: surgical, endovascular, or hybrid revascularization is recommended when feasible to minimize tissue loss, heal wounds, relieve pain, and preserve a functional limb, coordinated with wound care by a multispecialty care team.
Why the others are wrong
Venous stasis ulceration — venous ulcers typically sit over the medial malleolus, hurt less with leg elevation, and occur with palpable pulses and a normal ABI; each of those features is reversed here (trap: buzzword-matching "leg ulcer" to the most common ulcer type)
Intermittent claudication — claudication is exertional pain relieved by rest; pain at rest plus tissue loss means the disease has progressed beyond claudication (trap: premature closure on his previously known PAD stage)
Neuropathic ulceration — neuropathic ulcers are typically painless, occur over plantar pressure points, and usually accompany diabetes, which he does not have; his foot has severe rest pain and absent pulses (trap: confused-with-diabetic-foot-ulcer)
Acute thrombotic limb ischemia — a diseased artery in known PAD can thrombose suddenly and threaten the limb, but acute limb ischemia is defined by symptoms of less than 2 weeks, usually of abrupt onset; his 2-month progression to rest pain and a nonhealing ulcer is chronic (trap: separating acute from chronic limb-threatening ischemia by severity rather than duration)
Additional high-yield points
Symptom duration separates CLTI (more than 2 weeks) from acute limb ischemia (less than 2 weeks).
A normal or near-normal ABI does not exclude CLTI: the ABI is 0.90-1.40 in nearly one-quarter of patients with CLTI, so it is reasonable to add toe pressure/toe-brachial index (TBI) with waveforms, transcutaneous oxygen pressure, or skin perfusion pressure when CLTI is suspected.
Historically, CLTI carried a 1-year amputation rate of up to 30% and a 1-year mortality rate of 25%-35%.
Question 9CardiovascularMedium
A 60-year-old man has newly recognized atrial flutter with an uncertain time of onset. His ventricular rate is adequately controlled and he is hemodynamically stable. His CHA₂DS₂-VASc score is 3, and he has not yet been anticoagulated. He wishes to undergo elective cardioversion to restore sinus rhythm. Which of the following is the most appropriate timing for elective cardioversion?
AAfter 1 week of therapeutic anticoagulation
BAfter bridging with low-molecular-weight heparin
CImmediately, without any further evaluation
DAfter a normal transthoracic echocardiogram
EAfter ≥3 weeks of therapeutic anticoagulation
Reveal answer & full explanation
Correct answer: E — After ≥3 weeks of therapeutic anticoagulation
AAfter 1 week of therapeutic anticoagulation
BAfter bridging with low-molecular-weight heparin
CImmediately, without any further evaluation
DAfter a normal transthoracic echocardiogram
EAfter ≥3 weeks of therapeutic anticoagulation✓
Why After ≥3 weeks of therapeutic anticoagulation is correct
For atrial fibrillation or flutter of ≥48 hours or unknown duration, elective cardioversion requires either ≥3 weeks of uninterrupted therapeutic anticoagulation beforehand or a transesophageal echocardiogram excluding left atrial appendage thrombus, per current AHA/ACC/HRS guidance
This patient is not yet anticoagulated and onset is uncertain, so the appendage cannot be assumed clot-free
Anticoagulation must also continue ≥4 weeks after cardioversion regardless of CHA₂DS₂-VASc score because of atrial stunning
Why the others are wrong
Immediately, without any further evaluation — cardioverting an un-anticoagulated patient with unknown-duration arrhythmia risks dislodging a pre-existing appendage thrombus (anchoring on hemodynamic stability while ignoring stroke risk)
After 1 week of therapeutic anticoagulation — one week is too short to organize or resolve an existing appendage thrombus; the guideline threshold is 3 uninterrupted weeks, or a negative TEE if earlier cardioversion is desired (right-idea-wrong-duration)
After bridging with low-molecular-weight heparin — heparin bridging is not the guideline pathway for elective cardioversion; the requirement is 3 weeks of therapeutic anticoagulation or a negative TEE (right-idea-wrong-step)
After a normal transthoracic echocardiogram — imaging to exclude appendage thrombus is a legitimate alternative to 3 weeks of anticoagulation, but transthoracic echocardiography cannot reliably visualize the left atrial appendage, so a normal study does not exclude thrombus; the standard imaging pathway uses a TEE (right-idea-wrong-test)
Question 10CardiovascularMedium
A 70-year-old woman has a left ventricular ejection fraction of 30%, meeting criteria for an implantable cardioverter-defibrillator (ICD). She has advanced dementia, and her family reports she would not want aggressive interventions. She has been hospitalized three times this year for heart failure. Which of the following is the most appropriate next step?
Why Initiate goals-of-care discussion with family is correct
Although an EF ≤35% meets ICD criteria, device candidacy must be reconciled with prognosis and previously expressed values, not eligibility alone
Per current ACC/AHA/HRS guidance, shared decision-making incorporating the patient's goals and prognosis is required before primary-prevention ICD implantation
Advanced dementia plus three heart-failure admissions in a year signals a limited prognosis in which an ICD may prolong dying without improving quality of life
The family's report that she would decline aggressive care makes a surrogate goals-of-care (and palliative care) conversation the appropriate first step
Why the others are wrong
Implant a wearable cardioverter-defibrillator — substitutes one defibrillation-based intervention for another without addressing whether any defibrillation aligns with her goals (right-diagnosis-wrong-step)
Schedule outpatient electrophysiology consultation — advances the device pathway before clarifying goals, deferring rather than resolving the central decision (premature closure)
Proceed with implantation of a permanent ICD — implanting against her stated wishes violates patient autonomy and is inconsistent with her prognosis (anchoring on meeting the numerical EF criterion)
Request an ethics committee consultation — tempting because dementia and surrogate decision-making feel ethically complex, but ethics consultation is reserved for unresolved disagreement or uncertainty after a goals-of-care discussion has occurred; no such conversation has happened yet, and the family's report signals agreement rather than conflict (premature escalation)
That's 10 of 7,700+. Get the rest.
Unlock the full FirstPassPA bank: 7,700+ board-style questions across every organ system, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
Are these Cardiovascular PANRE practice questions free?
Yes. Each question shows the full vignette, the correct answer, and a complete explanation, with no email or account required. A free 7-day trial unlocks the full 7,700+ question bank, flashcards, and an AI tutor.
How much of the PANRE is Cardiovascular?
Cardiovascular makes up 12% of the PANRE content blueprint. FirstPassPA's timed PANRE exams are dealt to the same weights, so a practice exam carries the same share of Cardiovascular questions.
How should I use these questions?
Attempt each vignette before you reveal the answer, then read the full explanation even when you got it right: the reasons each wrong choice is wrong are where most of the learning is. When you are ready for more, practice Cardiovascular questions in the app, or take a full timed PANRE practice exam dealt to the blueprint weights.
Educational use only. These questions are a study aid for PA students and are not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.